• Conference Proceeding

Studying Cancer as an Adverse Outcome from Nononcological Therapies: Review of the Food and Drug Administration's Postmarketing Commitment Database (Meeting Abstract: 785)

Citation

Midkiff, K. D., Harris, D. H., Gilsenan, A. W., & Andrews, E. B. (2015). Studying Cancer as an Adverse Outcome from Nononcological Therapies: Review of the Food and Drug Administration's Postmarketing Commitment Database (Meeting Abstract: 785). In Pharmacoepidemiology and Therapeutic Risk Management, [24], pp. 448–449. .

Abstract